These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 31658967)
1. Development of Neutropenic Murine Models of Iron Overload and Depletion To Study the Efficacy of Siderophore-Antibiotic Conjugates. Kidd JM; Abdelraouf K; Nicolau DP Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658967 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Humanized Cefiderocol Exposure Is Unaltered by Host Iron Overload in the Thigh Infection Model. Kidd JM; Abdelraouf K; Nicolau DP Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658966 [TBL] [Abstract][Full Text] [Related]
3. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199 [TBL] [Abstract][Full Text] [Related]
4. Nakamura R; Ito-Horiyama T; Takemura M; Toba S; Matsumoto S; Ikehara T; Tsuji M; Sato T; Yamano Y Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262762 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model. Ghazi IM; Monogue ML; Tsuji M; Nicolau DP Int J Antimicrob Agents; 2018 Feb; 51(2):206-212. PubMed ID: 29111435 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model. Monogue ML; Tsuji M; Yamano Y; Echols R; Nicolau DP Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848004 [TBL] [Abstract][Full Text] [Related]
7. The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics. Page MGP Clin Infect Dis; 2019 Nov; 69(Suppl 7):S529-S537. PubMed ID: 31724044 [TBL] [Abstract][Full Text] [Related]
8. Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria. Diarra MS; Lavoie MC; Jacques M; Darwish I; Dolence EK; Dolence JA; Ghosh A; Ghosh M; Miller MJ; Malouin F Antimicrob Agents Chemother; 1996 Nov; 40(11):2610-7. PubMed ID: 8913474 [TBL] [Abstract][Full Text] [Related]
14. Humanized Exposures of Cefiderocol, a Siderophore Cephalosporin, Display Sustained in vivo Activity against Siderophore-Resistant Pseudomonas aeruginosa. Ghazi IM; Monogue ML; Tsuji M; Nicolau DP Pharmacology; 2018; 101(5-6):278-284. PubMed ID: 29471305 [TBL] [Abstract][Full Text] [Related]
15. Harnessing microbial iron chelators to develop innovative therapeutic agents. Ribeiro M; Sousa CA; Simões M J Adv Res; 2022 Jul; 39():89-101. PubMed ID: 35777919 [TBL] [Abstract][Full Text] [Related]
16. Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa. Ito A; Nishikawa T; Matsumoto S; Yoshizawa H; Sato T; Nakamura R; Tsuji M; Yamano Y Antimicrob Agents Chemother; 2016 Dec; 60(12):7396-7401. PubMed ID: 27736756 [TBL] [Abstract][Full Text] [Related]
17. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin "Trojan Horse" antibiotics and synthetic desferridanoxamine-antibiotic conjugates. Wencewicz TA; Möllmann U; Long TE; Miller MJ Biometals; 2009 Aug; 22(4):633-48. PubMed ID: 19221879 [TBL] [Abstract][Full Text] [Related]